Converted by EDGARwiz

[f3bandcleansing002.gif]

ASX RELEASE

17 September 2013

Cleansing Notice

We refer to the issue of a convertible security by Novogen Limited (Novogen) (ASX: NRT)

on 5 July 2013. Pursuant to a notice of conversion of a portion of the convertible security

representing in aggregate $75,000, Novogen issued 517,242 ordinary shares to Merrill Lynch

(Australia) Nominees Pty Limited ACN 003 925 031 FBO Hudson Bay Master Fund Limited

on 16 September 2013 (Shares).

For the purposes of section 708A(5)(e)(i) of the Corporations Act 2001 (Cth) (Corporations

Act) Novogen gives notice that:

Novogen issued the Shares without disclosure to investors under Part 6D.2 of the

Corporations Act;

as at the date of this notice, Novogen has complied with:

(a)

the provisions of Chapter 2M of the Corporations Act as they apply to

Novogen; and

(b)

section 674 of the Corporations Act; and

as at the date of this notice, there is no information that is “excluded information” (as

defined in subsections 708A(7) and 708A(8) of the Corporations Act) which is

required to be disclosed by Novogen.

Yours faithfully

[f3bandcleansing003.jpg]

Andrew Bursill

Company Secretary

981866_7_cleansing notice - hudson bay

Appendix 3B

New issue announcement

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement,

application for quotation of additional securities

and agreement

Information or documents not available now must be given to ASX as soon as available. Information and

documents given to ASX become ASX’s property and may be made public.

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005.

Name of entity

Novogen Limited (“Novogen”)

ABN

37 063 259 754

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

+Class of +securities issued or to be Ordinary fully paid share (Share)

issued

Number of +securities issued or to be 517,242 fully-paid Shares

issued (if known) or maximum

number which may be issued

Principal terms of the⁺securities (eg, Fully-paid ordinary voting shares

if options, exercise price and expiry Ranks pari passu with all existing Shares

date; if partly paid⁺securities, the

amount outstanding and due dates for

payment; if⁺convertible securities,

the conversion price and dates for

conversion)

+ See chapter 19 for defined terms.

24/10/2005Appendix 3B Page 1

Appendix 3B

New issue announcement

Do the⁺securities rank equally in All of the Shares referred to in Item 2 will rank pari passu

all respects from the date of with all existing Ordinary Shares.

allotment with an existing⁺class

of quoted⁺securities?

If the additional securities do not

rank equally, please state:

 the date from which they do

 the extent to which they

participate for the next

dividend, (in the case of a

trust, distribution) or interest

payment

 the extent to which they do

not rank equally, other than in

relation to the next dividend,

distribution

interest

payment

Issue price or consideration

Issue price per Share: $0.145

Purpose of the issue

The Shares referred to in Item 2 are issued pursuant to a

(If issued as consideration for the conversion notice received under the Convertible Securities

acquisition of assets, clearly Agreement announced to the market on 4 July 2013.

identify those assets)

Is the entity an +eligible entity No

that has obtained security holder

approval under rule 7.1A?

If Yes, complete sections 6b – 6h in

relation to the +securities the

subject of this Appendix 3B, and

comply with section 6i

The date the security holder N/A

resolution under rule 7.1A was

passed

+ See chapter 19 for defined terms.

Appendix 3B Page 2

1/1/2003

Appendix 3B

New issue announcement

Number of +securities issued 517,242 fully-paid Shares

without security holder approval

under rule 7.1

Number of +securities issued with N/A

security holder approval under

rule 7.1A

Number of +securities issued with N/A

security holder approval under

rule 7.3, or another specific

security holder approval (specify

date of meeting)

Number of +securities issued N/A

under an exception in rule 7.2

If +securities issued under rule N/A

7.1A, was issue price at least 75%

of 15 day VWAP as calculated

under rule 7.1A.3? Include the

+issue date and both values.

Include the source of the VWAP

calculation.

If +securities were issued under N/A

rule

7.1A

for

non-cash

consideration, state date on

which valuation of consideration

was released to ASX Market

Announcements

Calculate the entity's remaining N/A

issue capacity under rule 7.1 and

rule 7.1A – complete Annexure 1

and release to ASX Market

Announcements

+ See chapter 19 for defined terms.

24/10/2005Appendix 3B Page 3

Appendix 3B

New issue announcement

+Issue dates

16 September 2013

Note: The issue date may be

prescribed by ASX (refer to the

definition of issue date in rule

19.12). For example, the issue

date for a pro rata entitlement

issue must comply with the

applicable

timetable

Appendix 7A.

Cross reference: item 33 of

Appendix 3B.

Number

⁺Class

Number and

⁺class of all

⁺securities quoted on ASX 144,208,463

Ordinary Shares

(including the securities in

clause 2 if applicable)

Number

⁺Class

Number and

⁺class of all 6,007,216

Unlisted options with various

⁺securities not quoted on ASX

exercise dates and prices.

(including the securities in clause

2 if applicable)

Unlisted convertible note with a

face value of $340,000

60,000,000

Unlisted convertible notes, with

aggregate

face

values

$1,500,000

Dividend policy (in the case of a N/A

trust, distribution policy) on the

increased capital (interests)

Part 2 - Bonus issue or pro rata issue

Is security holder approval

required?

Is the issue renounceable or non-

renounceable?

Ratio in which the⁺securities

will be offered

+ See chapter 19 for defined terms.

Appendix 3B Page 4

1/1/2003

Appendix 3B

New issue announcement

⁺Class of⁺securities to which the

offer relates

⁺Record date to determine

entitlements

Will holdings on different

registers (or subregisters) be

aggregated

for

calculating

entitlements?

Policy for deciding entitlements

in relation to fractions

Names of countries in which the

entity has⁺security holders who

will not be sent new issue

documents

Note: Security holders must be told how their

entitlements are to be dealt with.

Cross reference: rule 7.7.

Closing date for receipt of

acceptances or renunciations

Names of any underwriters

Amount of any underwriting fee

or commission

Names of any brokers to the

issue

Fee or commission payable to the

broker to the issue

Amount of any handling fee

payable to brokers who lodge

acceptances or renunciations on

behalf of⁺security holders

If the issue is contingent on

⁺security holders’ approval, the

date of the meeting

+ See chapter 19 for defined terms.

24/10/2005Appendix 3B Page 5

Appendix 3B

New issue announcement

Date entitlement and acceptance

form and prospectus or Product

Disclosure Statement will be sent

to persons entitled

If the entity has issued options,

and the terms entitle option

holders

participate

exercise, the date on which

notices will be sent to option

holders

Date rights trading will begin (if

applicable)

Date rights trading will end (if

applicable)

How do⁺security holders sell

their entitlements in full through

a broker?

How do⁺security holders sell

part of their entitlements

through a broker and accept for

the balance?

How do⁺security holders dispose

of their entitlements (except by

sale through a broker)?

⁺Despatch date

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

Type of securities

(tick one)

(a)

Securities described in Part 1

(b)

All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid,

employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible

securities

+ See chapter 19 for defined terms.

Appendix 3B Page 6

1/1/2003

Appendix 3B

New issue announcement

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or

documents

If the⁺securities are⁺equity securities, the names of the 20 largest holders of the

additional⁺securities, and the number and percentage of additional⁺securities

held by those holders

If the⁺securities are⁺equity securities, a distribution schedule of the additional

⁺securities setting out the number of holders in the categories

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over

A copy of any trust deed for the additional⁺securities

Entities that have ticked box 34(b)

Number of securities for which

⁺quotation is sought

Class of⁺securities for which

quotation is sought

Do the⁺securities rank equally in

all respects from the date of

allotment with an existing⁺class

of quoted⁺securities?

If the additional securities do not

rank equally, please state:

 the date from which they do

 the extent to which they

participate for the next

dividend, (in the case of a

trust, distribution) or interest

payment

 the extent to which they do

not rank equally, other than in

relation to the next dividend,

distribution

interest

payment

+ See chapter 19 for defined terms.

24/10/2005Appendix 3B Page 7

Appendix 3B

New issue announcement

Reason for request for quotation

now

Example: In the case of restricted securities, end

of restriction period

(if issued upon conversion of

another security, clearly identify

that other security)

Number

⁺Class

Number and

⁺class of all

⁺securities quoted on ASX

(including the securities in clause

38)

+ See chapter 19 for defined terms.

Appendix 3B Page 8

1/1/2003

Appendix 3B

New issue announcement

Quotation agreement

⁺Quotation of our additional⁺securities is in ASX’s absolute discretion. ASX

may quote the⁺securities on any conditions it decides.

We warrant the following to ASX.



The issue of the⁺securities to be quoted complies with the law and is

not for an illegal purpose.



There is no reason why those⁺securities should not be granted

⁺quotation.



An offer of the⁺securities for sale within 12 months after their issue

will not require disclosure under section 707(3) or section 1012C(6) of

the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be

able to give this warranty



Section 724 or section 1016E of the Corporations Act does not apply to

any applications received by us in relation to any⁺securities to be

quoted and that no-one has any right to return any⁺securities to be

quoted under sections 737, 738 or 1016F of the Corporations Act at the

time that we request that the⁺securities be quoted.



If we are a trust, we warrant that no person has the right to return the

⁺securities to be quoted under section 1019B of the Corporations Act at

the time that we request that the⁺securities be quoted.

We will indemnify ASX to the fullest extent permitted by law in respect of any

claim, action or expense arising from or connected with any breach of the

warranties in this agreement.

We give ASX the information and documents required by this form. If any

information or document not available now, will give it to ASX before

⁺quotation of the⁺securities begins. We acknowledge that ASX is relying on

the information and documents. We warrant that they are (will be) true and

complete.

Sign here:

...........................................................

Date: 16 September 2013

(Company secretary)

Print name:

......Andrew Bursill..............................

== == == == ==

+ See chapter 19 for defined terms.

24/10/2005Appendix 3B Page 9

Appendix 3B

New issue announcement

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A

for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate "A", the base figure from which the placement capacity is

calculated

Insert number of fully paid +ordinary securities on 103,805,676

issue 12 months before the +issue date or date of

agreement to issue

Add the following:

• Number of fully paid +ordinary securities issued

in that 12 month period under an exception in rule

7.2

34,470,357

• Number of fully paid +ordinary securities issued

in that 12 month period with shareholder approval

• Number of partly paid +ordinary securities that

became fully paid in that 12 month period

Note:

• Include only ordinary securities here – other

classes of equity securities cannot be added

• Include here (if applicable) the securities the

subject of the Appendix 3B to which this form is

annexed

• It may be useful to set out issues of securities on

different dates as separate line items

Subtract the number of fully paid +ordinary -

securities cancelled during that 12 month period

"A"

138,276,033

+ See chapter 19 for defined terms.

Appendix 3B Page 10

1/1/2003

Appendix 3B

New issue announcement

Step 2: Calculate 15% of "A"

"B"

0.15

Multiply "A" by 0.15

20,741,404

Step 3: Calculate "C", the amount of placement capacity under rule 7.1 that

has already been used

Insert number of +equity securities issued

or agreed to be issued in that 12 month

period not counting those issued:

9,932,430

• Under an exception in rule 7.2

• Under rule 7.1A

• With security holder approval under rule

7.1 or rule 7.4

Note:

• This applies to equity securities, unless

specifically excluded – not just ordinary

securities

• Include here (if applicable) the securities

the subject of the Appendix 3B to which this

form is annexed

• It may be useful to set out issues of

securities on different dates as separate

line items

"C"

9,932,430

Step 4: Subtract "C" from ["A" x "B"] to calculate remaining placement

capacity under rule 7.1

"A" x 0.15

20,741,404

Note: number must be same as shown in

Step 2

Subtract "C"

9,932,430

Note: number must be same as shown in

Step 3

Total ["A" x 0.15] – "C"

10,808,974

+ See chapter 19 for defined terms.

24/10/2005Appendix 3B Page 11

Appendix 3B

New issue announcement

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate "A", the base figure from which the placement capacity is

calculated

"A"

N/A

Note: number must be same as shown in

Step 1 of Part 1

Step 2: Calculate 10% of "A"

"D"

N/A

Multiply "A" by 0.10

N/A

Step 3: Calculate "E", the amount of placement capacity under rule 7.1A that

has already been used

Insert number of +equity securities issued N/A

or agreed to be issued in that 12 month

period under rule 7.1A

Notes:

• This applies to equity securities – not just

ordinary securities

• Include here – if applicable – the

securities the subject of the Appendix 3B to

which this form is annexed

• Do not include equity securities issued

under rule 7.1 (they must be dealt with in

Part 1), or for which specific security holder

approval has been obtained

• It may be useful to set out issues of

securities on different dates as separate

line items

"E"

N/A

+ See chapter 19 for defined terms.

Appendix 3B Page 12

1/1/2003

Appendix 3B

New issue announcement

Step 4: Subtract "E" from ["A" x "D"] to calculate remaining placement

capacity under rule 7.1A

"A" x 0.10

N/A

Note: number must be same as shown in

Step 2

Subtract "E"

N/A

Note: number must be same as shown in

Step 3

Total ["A" x 0.10] – "E"

Note: this is the remaining placement

capacity under rule 7.1A

+ See chapter 19 for defined terms.

24/10/2005Appendix 3B Page 13